TipRanks
Quince Therapeutics (QNCX)
NASDAQ:QNCX
US Market
QNCX
Quince Therapeutics
RESEARCH TOOLSreports
Want to see QNCX full AI Analyst Report?

Quince Therapeutics (QNCX) Ratios

1,044 Followers

Quince Therapeutics Ratios

QNCX's free cash flow for Q2 2026 was $0.00. For the 2026 fiscal year, QNCX's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Mar 24Dec 22
Liquidity Ratios
Current Ratio
 14.52 0.53 6.05 8.09 30.55
Quick Ratio
 14.52 0.53 6.05 8.09 30.55
Cash Ratio
 13.64 0.13 0.85 2.17 14.53
Solvency Ratio
 -5.96 -0.65 -0.67 -0.33 -15.51
Operating Cash Flow Ratio
 -5.52 -0.96 -4.38 -1.91 -14.35
Short-Term Operating Cash Flow Coverage
 0.00 -2.30 0.00 -285.81 0.00
Net Current Asset Value
$ 107.90M$ -106.34M$ -40.30M$ -17.68M$ 90.43M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.20 0.13 0.08 <0.01
Debt-to-Equity Ratio
 0.00 -0.52 0.49 0.16 <0.01
Debt-to-Capital Ratio
 0.00 -1.07 0.33 0.14 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 >-0.01 0.32 0.14 0.00
Financial Leverage Ratio
 1.14 -2.62 3.80 2.12 1.03
Debt Service Coverage Ratio
 0.00 -4.65 0.00 -415.98 -89.26
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 -91.58
Debt to Market Cap
 0.00 0.11 0.18 0.35 0.00
Interest Debt Per Share
 0.00 73.74 68.47 0.37 0.03
Net Debt to EBITDA
 1.60 -0.16 -0.24 0.26 0.87
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
97.71%103.98%100.15%99.38%99.45%
EBT Per EBIT
76.52%160.16%99.05%91.22%99.86%
Return on Assets (ROA)
-74.58%-89.80%-49.64%-17.42%-49.72%
Return on Equity (ROE)
-413.28%235.14%-188.51%-36.89%-51.36%
Return on Capital Employed (ROCE)
-107.08%-100.26%-53.44%-20.29%-51.58%
Return on Invested Capital (ROIC)
-104.64%-73.69%-53.39%-20.16%-51.07%
Return on Tangible Assets
-74.58%-326.72%-104.40%-31.73%-52.71%
Earnings Yield
-48.10%-50.04%-70.24%-80.27%-241.96%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 <0.01 0.06 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 -47.00K -5.71K 0.00 0.00 0.00
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 47.00K 5.71K 0.00 0.00 0.00
Operating Cycle
 0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -7.65 -165.38 -147.49 -0.49 -1.31
Free Cash Flow Per Share
 -7.66 -166.78 -148.68 -0.50 -1.32
CapEx Per Share
 0.01 1.41 1.19 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.01 1.01 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
 -601.58 -117.68 -124.14 -114.33 -331.11
Capital Expenditure Coverage Ratio
 -601.58 -117.68 -124.14 -114.33 -331.11
Operating Cash Flow Coverage Ratio
 0.00 -2.24 -2.15 -1.32 -97.21
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-538.50%-24.89%-39.75%-47.19%-206.88%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.45 -1.99 -1.43 -1.25 -0.41
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 1.77 -4.70 2.68 0.46 0.21
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.19 -4.02 -2.52 -2.12 -0.48
Price-to-Operating Cash Flow Ratio
 -4.10 -4.05 -2.54 -2.14 -0.48
Price-to-Earnings Growth (PEG) Ratio
 -0.02 -0.07 -0.03 0.03 <0.01
Price-to-Fair Value
 1.77 -4.70 2.68 0.46 0.21
Enterprise Value Multiple
 1.48 -2.24 -2.49 -1.20 0.45
Enterprise Value
 -107.25M 180.49M 89.50M 32.16M -22.78M
EV to EBITDA
 1.48 -2.24 -2.49 -1.20 0.45
EV to Sales
 0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 2.28 -4.32 -2.78 -1.74 0.52
EV to Operating Cash Flow
 2.29 -4.36 -2.81 -1.76 0.52
Tangible Book Value Per Share
 17.69 -413.33 -138.22 0.10 2.83
Shareholders’ Equity Per Share
 17.69 -142.58 139.36 2.28 3.00
Tax and Other Ratios
Effective Tax Rate
 0.02 -0.04 >-0.01 <0.01 <0.01
Revenue Per Share
 0.00 0.00 0.00 0.00 0.00
Net Income Per Share
 -15.08 -335.27 -262.71 -0.84 -1.54
Tax Burden
 0.98 1.04 1.00 0.99 0.99
Interest Burden
 1.31 1.00 1.57 1.16 1.01
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.51 0.49 0.56 0.58 0.85
Currency in USD